Medpace Holdings, Inc. Additional Paid in Capital, Common Stock
Medpace Holdings, Inc. (MEDP) had Additional Paid in Capital, Common Stock of $964.18 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-07-23
- 2026-06-30: Additional Paid in Capital, Common Stock $964.18M.
- 2026-03-31: Additional Paid in Capital, Common Stock $953.42M.
- 2025-12-31: Additional Paid in Capital, Common Stock $935.83M.
- 2025-09-30: Additional Paid in Capital, Common Stock $907.48M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $964.18M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $953.42M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $935.83M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $907.48M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $893.17M 10-Q · filed 2025-07-22 |
| 2025-03-31 | $886.88M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $844.05M 10-K · filed 2026-02-10 |
| 2024-09-30 | $836.90M 10-Q · filed 2024-10-22 |
| 2024-06-30 | $818.90M 10-Q · filed 2024-07-23 |
| 2024-03-31 | $814.65M 10-Q · filed 2024-04-23 |
| 2023-12-31 | $802.68M 10-K · filed 2025-02-11 |
| 2023-09-30 | $795.99M 10-Q · filed 2023-10-24 |
| 2023-06-30 | $785.29M 10-Q · filed 2023-07-25 |
| 2023-03-31 | $778.69M 10-Q · filed 2023-04-25 |
| 2022-12-31 | $770.79M 10-K · filed 2024-02-13 |
| 2022-09-30 | $759.99M 10-Q · filed 2022-10-25 |
| 2022-06-30 | $753.30M 10-Q · filed 2022-07-26 |
| 2022-03-31 | $746.12M 10-Q · filed 2022-04-26 |
| 2021-12-31 | $727.86M 10-K · filed 2023-02-14 |
| 2021-09-30 | $721.60M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $716.55M 10-Q · filed 2021-07-27 |
| 2021-03-31 | $707.88M 10-Q · filed 2021-04-27 |
| 2020-12-31 | $695.90M 10-K · filed 2022-02-15 |
| 2020-09-30 | $687.62M 10-Q · filed 2020-10-27 |
| 2020-06-30 | $676.62M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $673.37M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $666.59M 10-K · filed 2021-02-16 |
| 2019-09-30 | $663.04M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $651.78M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $643.50M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $639.38M 10-K · filed 2020-02-25 |
| 2018-09-30 | $636.54M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $634.47M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $632.37M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $630.34M 10-K · filed 2019-02-26 |
| 2017-09-30 | $628.56M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $627.41M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $625.30M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $623.63M 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |